Phenotypic classification of human CD4+ T cell subsets and their differentiation

Area of Science:

• Immunology
• Cell Biology

Background:

• CD4(+) T cells are crucial for immune responses, with T helper 1 (T(h)1) and T helper 2 (T(h)2) cells being major functional subsets.
• Phenotypic classification of human CD4(+) T cells remains limited, hindering a comprehensive understanding of their distinct roles.

Purpose of the Study:

• To investigate the functional subsets of human CD4(+) T cells using flow cytometry.
• To classify these subsets based on the expression of CD27, CD28, CD45RA, and CCR7 markers.
• To analyze the cytokine production patterns of identified subsets to elucidate their functional characteristics and differentiation pathways.

Main Methods:

• Utilized seven- and eight-color flow cytometry for detailed analysis of human CD4(+) T cells.
• Classified T cell subsets based on the expression of four key markers: CD27, CD28, CD45RA, and CCR7.
• Stimulated identified subsets with phorbol myristate acetate and ionomycin, anti-CD3/anti-CD28 monoclonal antibodies, or human cytomegalovirus antigens to assess cytokine production (IFN-gamma and IL-4).

Main Results:

• Identified five major CD4(+) T cell subsets based on the four markers.
• Correlated specific marker combinations with distinct T cell populations: naive (CCR7(+)CD45RA(+)CD27(+)CD28(+)), central memory (CCR7(+)CD45RA(-)CD27(+)CD28(+)), and effector memory (CCR7(-)CD45RA(-)CD27(+)CD28(+)).
• Determined that CCR7(-)CD45RA(-)CD27(-)CD28(-) subsets predominantly contain T(h)1 effector cells, while CCR7(-)CD45RA(-)CD27(-)CD28(+) subsets include T(h)1 and T(h)2 effector memory/effector cells.

Conclusions:

• The four-marker classification system effectively distinguishes naive, memory, and effector T(h)1/T(h)2 cells within the human CD4(+) T cell population.
• The CCR7(-)CD45RA(-)CD27(-)CD28(-) subset is a primary source of IFN-gamma, characteristic of T(h)1 cells.
• The CCR7(-)CD45RA(-)CD27(-)CD28(+) subset produces both IL-4 and IFN-gamma, indicating a mixed T(h)1/T(h)2 effector phenotype, and provides insights into CD4(+) T cell differentiation pathways.